Thomas Monath

Thomas Monath was Chief Scientific Officer and Executive Director of Acambis from 1992 to 2006, where he oversaw the development of dengue, West Nile, Japanese encephalitis, yellow fever, C. difficile, and smallpox vaccines. Prior to Acambis, Dr. Monath served in the U.S. Public Health Service and the U.S. Army for 24 years. During that time, he was Director of the Division of Vector-Borne Diseases at the CDC and Chief of the Virology Division at the U.S. Army Medical Research Institute of Infectious Diseases. Most recently, Dr. Monath was a partner in the Pandemic and Biodefense Fund at Kleiner Perkins Caufield & Byers and an Adjunct Professor at the Harvard School of Public Health.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Vaxess Technologies

Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. They are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.


Employees

11-50

Links